{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F1162024-traverse-Li5m9G4c","width":444,"version":"1.0","type":"rich","title":"1.16.2024 - TRAVERSE","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/663256b1-bfbb-4163-ab2b-0cc6d70e2afa\" height=\"200\" width=\"100%\" title=\"1.16.2024 - TRAVERSE\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's QuadCast as we highlight if testosterone replacement therapy in men with Low T affects prostate cancer risk, the combination of pyrotinib + capecitabine + brain RT, the importance of dose to pulmonary veins in the development of A-fib, and more."}